NCT05111405

Brief Summary

A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Patient reported outcomes will be collected at 6 and 6 weeks, 3, 6, and 12 months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

June 20, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

3.6 years

First QC Date

October 27, 2021

Last Update Submit

February 26, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual Analog Scale- Pain

    Participants overall assessment of their pain at maximal key pinch loading on a 10 cm visual analogue scale

    12 Months

  • Disabilities of the Arm, Shoulder and Hand Questionnaire

    A 30 Item questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores will indicated better outcomes.Lower scores will indicate better outcomes.

    12 Months

  • Patient Related Wrist Evaluation Questionnaire

    A 15 item questionnaire to measure wrist pain and disability pain in activities of daily living

    12 Months

Secondary Outcomes (4)

  • Operative Time

    Intraoperative

  • Strength

    12 Months

  • Range of Motion

    12 Months

  • Work Productivity and Activity Impairment: Specific Health Problem Questionnaire

    12 Months

Study Arms (2)

Trapezial excision with or without soft tissue interposition and /or ligament reconstruction

OTHER

The participating surgeon will perform their usual version of a trapeziectomy and thumb metacarpal using either FCR tendon or abductor hallucis longs (APL) tendon. Tendon interposition will be left to the surgeon's discretion.

Procedure: CMC Arthroplasty

Suture button suspension arthroplasty (SBS)

OTHER

Dorso-radial incision, capsulotomy between extensor pollicis brevis (EPB) and APL protecting the radial artery. A second incision is made on dorsum of hand between the 2nd and 3rd MCs. A cannulated drill with suture passer is passed from base of 1st MC to mid 2nd MC. The TightropeTM is passed from 1st to second MC with one button on the base of the 1st MC. Trapeziectomy is then performed using a cruciate osteotomy and rongeurs. The thumb is adducted against index MC to avoid excessive tightening and the suture is tied over a second button on the 2nd MC. Closure of capsule with Vicryl. Closure of skin with running Prolene suture.

Procedure: CMC Arthroplasty

Interventions

Surgical intervention to treat CMC arthritis

Suture button suspension arthroplasty (SBS)Trapezial excision with or without soft tissue interposition and /or ligament reconstruction

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age fifty years or older
  • Isolated carpometacarpal (trapeziometacarpal) osteoarthritis
  • Failure to respond to non-operative management
  • Willing and able to consent on their own behalf and follow the protocol and clinical visits as described
  • Able to read and understand English or have interpreter available

You may not qualify if:

  • Previous surgery for CMC arthritis
  • Duration of symptoms for less than 6 months
  • Greater than or equal to 30 degrees of ipsilateral metacarpophalangeal (MCP) hyperextension
  • Scaphotrapeziotrapezoidal (stage 4 CMC) arthritis
  • Other significant ipsilateral wrist or hand pathology
  • A history of inflammatory arthropathy
  • A requirement for concomitant surgery for another condition
  • Any previous hand or wrist fracture
  • Likely problems, in the judgement of the investigators, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged patients without adequate support, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

South Campus Research Unit for Bone and Soft Tissue

Calgary, Alberta, T3M1M4, Canada

RECRUITING

Fraser Orthopaedic Research Society

New Westminster, British Columbia, V3L 0E4, Canada

RECRUITING

MeSH Terms

Conditions

Arthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Central Study Contacts

Bertrand Perey

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Multicenter, randomized, prospective trial.
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2021

First Posted

November 8, 2021

Study Start

June 20, 2022

Primary Completion

February 1, 2026

Study Completion

May 1, 2026

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations